Abstract

Simple SummaryMinimal invasive surgery (MIS) has been associated with lower disease-free survival than open surgery among women who underwent radical hysterectomy for early-stage cervical cancer. However, the mechanisms by which MIS increases mortality in cervical cancer remain uncertain. We aimed to determine if surgical practice among centers using robotic surgery has an impact on oncological outcomes. We evaluated 215 women with early-stage cervical cancer (≤IB1 or IIA1, FIGO 2009) who underwent robot-assisted radical hysterectomy in five Spanish tertiary centers between 2009 and 2018. A higher surgical volume, higher participation in clinical trials, higher rate of MRI use for diagnosis, greater use of sentinel lymph node biopsies, and a favorable learning curve with low rates of early recurrences were observed for the centers with better oncological outcomes. These factors might have a significant impact on oncological outcomes in all surgical approaches.This study aimed to assess whether surgical practice had a significant impact on oncological outcomes among women who underwent robot-assisted radical hysterectomy for early-stage cervical cancer (≤IB1 or IIA1, FIGO 2009). The secondary objective was to audit the pre-surgical quality indicators (QI) proposed by the European Society of Gynaecological Oncology (ESGO). The top 5 of 10 centers in Spain and Portugal were included in the analysis. The hospitals were divided into group A (n = 118) and group B (n = 97), with recurrence rates of <10% and >10%, respectively. After balancing both groups using the propensity score, the ORs for all events were higher and statistically significant for group B (recurrences OR = 1.23, 95% CI = 1.13–1.15, p-value = 0.001; death OR = 1.10, 95% CI = 1.02–1.18, p-value = 0.012; disease-specific mortality ORr = 1.11, 95% CI = 1.04–1.19, p-value = 0.002). A higher surgical volume, higher participation in clinical trials, higher rate of MRI use for diagnosis, greater use of sentinel lymph node biopsies, and a favorable learning curve with low rates of early recurrences were observed among the centers with better oncological outcomes. These factors might have a significant impact on oncological outcomes not only after robot-assisted surgery, but also after laparoscopies and open surgeries in the treatment of cervical cancer.

Highlights

  • The surgical approach for treating women with early-stage cervical cancer changed in favor of open surgery in 2018 after the publication of the LACC trial [1]

  • The disease-free survival (DFS) rate at 4.5 years was lower for patients who underwent minimally invasive surgery (MIS) than for those subjected to open surgery (86.0% vs. 96.5%, respectively)

  • A target of recurrence rate 10% was applied, according to the quality indicators (QI) of the European Society of Gynaecological Oncology (ESGO) [4], in order to divide the hospitals into group A (n = 118) and group B (n = 97), respectively (Table 1)

Read more

Summary

Introduction

The surgical approach for treating women with early-stage cervical cancer changed in favor of open surgery in 2018 after the publication of the LACC trial [1]. The European multicenter retrospective SUCCOR study observed a similar risk of relapse in patients affected by early-stage cervical cancer who had undergone MIS with protective surgical maneuvers when compared to open surgery [3]. The European Society of Gynaecological Oncology (ESGO) aims to homogenize the clinical and surgical practice in gynecological cancers. They published quality indicators (QIs) for treating cervical cancer in 2020 [4] to promote good clinical practice. To attain the best oncological outcomes, further research and enhanced surgical training are recommended

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call